ストックスクリーナーアプリを入手
8.92
3.60%
0.31
アフターアワーズ：
8.92
前日終値:
$8.61
開ける：
$8.6
24時間の取引高:
233.88K
Relative Volume:
0.76
時価総額：
$447.55M
収益：
-
当期純損益:
$-83.74M
株価収益率:
-5.5404
EPS:
-1.61
ネットキャッシュフロー:
$-64.98M
1週間 パフォーマンス:
+18.15%
1か月 パフォーマンス:
-16.95%
6か月 パフォーマンス:
-65.67%
1年 パフォーマンス:
-38.27%
1日の値動き範囲:
$8.30
$8.99
1週間の範囲:
$7.52
$8.99
52週間の値動き範囲:
$6.42
$29.60
Tyra Biosciences Inc Stock (TYRA) Company Profile
TYRA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TYRA
Tyra Biosciences Inc
|
8.92 | 447.55M | 0 | -83.74M | -64.98M | -1.61 |
|
VRTX
Vertex Pharmaceuticals Inc
|
489.10 | 127.47B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.16 | 62.43B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
596.20 | 37.03B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
234.56 | 31.06B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
230.98 | 26.16B | 3.81B | -644.79M | -669.77M | -6.24 |
Tyra Biosciences Inc Stock (TYRA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-01-07 | 開始されました | UBS | Buy |
| 2024-10-18 | アップグレード | BofA Securities | Neutral → Buy |
| 2024-08-15 | 開始されました | Piper Sandler | Overweight |
| 2023-12-15 | ダウングレード | BofA Securities | Buy → Neutral |
| 2023-06-30 | 開始されました | Wedbush | Outperform |
| 2023-02-03 | 開始されました | Oppenheimer | Outperform |
| 2022-06-23 | 開始されました | H.C. Wainwright | Buy |
| 2022-03-08 | アップグレード | Jefferies | Hold → Buy |
| 2021-11-08 | ダウングレード | Jefferies | Buy → Hold |
| 2021-10-11 | 開始されました | BofA Securities | Buy |
| 2021-10-11 | 開始されました | Cowen | Outperform |
| 2021-10-11 | 開始されました | Jefferies | Buy |
すべてを表示
Tyra Biosciences Inc (TYRA) 最新ニュース
Vanguard Group Inc. Sells 37,643 Shares of Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World
Wellington Management Group LLP Has $1.32 Million Stock Position in Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World
American Century Companies Inc. Sells 20,857 Shares of Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World
KLP Kapitalforvaltning AS Buys New Stake in Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World
TYRA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Tyra Biosciences Inc and Encourages Investors to Contact the Firm! - ACCESS Newswire
Advanced Urothelial Carcinoma Clinical Trials and Studies 2025: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies - Barchart.com
Raymond James Financial Inc. Invests $761,000 in Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World
HC Wainwright Predicts Reduced Earnings for Tyra Biosciences - Defense World
Tyra Biosciences stock hits 52-week low at $8.14 - Investing.com Australia
Tyra Biosciences stock hits 52-week low at $8.14 By Investing.com - Investing.com South Africa
(TYRA) Technical Data - news.stocktradersdaily.com
Tyra Biosciences (NASDAQ:TYRA) Given Buy Rating at HC Wainwright - Defense World
H.C. Wainwright maintains $30 target on Tyra Biosciences stock By Investing.com - Investing.com Canada
Tyra Biosciences, Inc. (NASDAQ:TYRA) Shares Sold by Swiss National Bank - Defense World
What is Wedbush’s Estimate for TYRA FY2029 Earnings? - Defense World
Tyra Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights - Citizen Tribune
Wedbush Reiterates “Outperform” Rating for Tyra Biosciences (NASDAQ:TYRA) - Defense World
Companies Like Tyra Biosciences (NASDAQ:TYRA) Are In A Position To Invest In Growth - Yahoo Finance
Charles Schwab Investment Management Inc. Trims Stock Position in Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World
Tyra Biosciences (NASDAQ:TYRA) Shares Gap Up After Better-Than-Expected Earnings - Defense World
Tyra Biosciences Advances Precision Medicine Pipeline - TipRanks
Tyra Biosciences, Inc. (NASDAQ:TYRA) Shares Bought by Bank of New York Mellon Corp - Defense World
Tyra Biosciences stock hits 52-week low at $9.9 amid market challenges By Investing.com - Investing.com South Africa
Tyra Biosciences stock hits 52-week low at $9.9 amid market challenges - Investing.com
Tyra Biosciences, Inc. (NASDAQ:TYRA) Receives $30.50 Consensus Target Price from Analysts - Defense World
Trend Tracker for (TYRA) - news.stocktradersdaily.com
Victory Capital Management Inc. Purchases 26,560 Shares of Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World
Tyra Biosciences to Present at Oppenheimer's 34th Annual Healthc - GuruFocus.com
US Bancorp DE Purchases Shares of 3,612 Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World
Incyte, Tesla And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga India
Why Precision BioSciences Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket - NewsBreak: Local News & Alerts
Tyra Biosciences (NASDAQ:TYRA) Sees Large Volume Increase – Should You Buy? - Defense World
Tyra Biosciences Inc expected to post a loss of 48 cents a shareEarnings Preview - TradingView
(TYRA) On The My Stocks Page - Stock Traders Daily
Tyra Biosciences (TYRA) Expected to Announce Quarterly Earnings on Tuesday - Defense World
Tyra Biosciences stock hits 52-week low at $10.62 amid market challenges - Investing.com Australia
Tyra Biosciences stock hits 52-week low at $10.62 amid market challenges By Investing.com - Investing.com South Africa
Rhumbline Advisers Grows Stake in Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World
BALVERSA Adoption on the Rise: Meeting Unmet Needs in Advanced Urothelial Cancer | DelveInsight - GlobeNewswire Inc.
Tyra Biosciences, Inc. (NASDAQ:TYRA) Sees Large Growth in Short Interest - Defense World
Advanced Urothelial Carcinoma Clinical Trial Pipeline - GlobeNewswire
Advanced Urothelial Carcinoma Clinical Trial Pipeline Analysis Demonstrates 20+ Key Companies at the Horizon Expected to Transform the Treatment Paradigm, Assesses DelveInsight - GlobeNewswire
Non-Muscle Invasive Bladder Cancer Clinical and Non-Clinical - openPR
(TYRA) Investment Report - Stock Traders Daily
Tyra Biosciences: FGFR1/2 Driven AE Data Spooked The Market - Seeking Alpha
Brokerages Set Tyra Biosciences, Inc. (NASDAQ:TYRA) Price Target at $30.50 - Defense World
Tyra Biosciences Inc (TYRA) 財務データ
収益
当期純利益
現金流量
EPS
2.51%
大文字化:
|
ボリューム (24 時間):